It is in fact the same ANDA No. 205037 that was used in August 2013 by Agila Strides who submitted ANDA No. 205037 to the FDA for Daptomycin for Injection, a generic version of Cubicin. A patent for a daptomycin injectable formulation incorporating TPM was filed around the same time.
This really does start to make things interesting ?? Give us your professional wisdom @hottod
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.86M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.4¢ | $28.1K | 5.620M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 43 | 40990100 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 450000 | 1 |
View Market Depth
| Last trade - 15.47pm 31/07/2025 (20 minute delay) ? |
| AVE (ASX) Chart |